AbbVie Inc. is a global biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing medicines and therapies for complex and serious diseases. AbbVie’s current portfolio spans immunology, oncology, neuroscience, eye care, and aesthetics, with additional products in virology, gastroenterology, and other specialty areas. The company serves patients through prescription medicines and advanced therapies used in rheumatology, dermatology, gastroenterology, blood cancers, migraine, psychiatric disorders, eye conditions, and certain chronic infectious diseases. AbbVie also markets products through its Allergan Aesthetics business, giving it a presence in both therapeutic healthcare and medical aesthetics. Headquartered in North Chicago, Illinois, AbbVie plays a significant role in the global pharmaceutical market by combining research, manufacturing, and commercialization across multiple high-value specialty segments.